06 Jul 2017 --- Following the receipt of all required regulatory approvals, Lonza has completed the acquisition of Capsugel S.A from KKR for US$5.5 billion in cash, including refinancing of existing Capsugel debt of approximately US$2 billion. The acquisition of Capsugel, which supplies advanced oral dosage delivery technologies with a leading position in hard capsules, is expected to be accretive to Lonza’s core earnings per share in the first full year post closing.
